Hormone Pellets for Menopause: 5 Questions Before the Insertion
Menopause & HormonesArticlePellets are often sold as a set-it-and-forget-it fix. Here is what national guidance says, and what to ask before a pellet goes under your skin.

In this article
- What national guidance says first
- 1. “Is this pellet compounded, or an FDA-approved product?”
- 2. “What happens if the dose turns out too high?”
- 3. “How will you protect my uterus?”
- 4. “How will you decide when I need the next one?”
- 5. “What will this cost over a year, and does insurance pay any of it?”
- Bring a second opinion if you’re unsure
Hormone pellets are small cylinders of estradiol, testosterone or both, placed under the skin of the hip or buttock through a tiny cut. They release hormone for months, so you don’t have to remember a pill, patch or gel. Pellets are often marketed as “bioidentical,” and insurance may not cover them. Before you book an insertion, bring these five questions so the decision rests on more than the convenience.
What national guidance says first
Hormone therapy is the most effective treatment for hot flashes and night sweats, according to the 2022 Menopause1 Society position statement. The statement adds that risks depend on the type, dose, route and timing of the hormones.1 The debate is about pellets and compounded products, not about hormone therapy itself.
- ACOG2 (the American College of Obstetricians and Gynecologists) says compounded “bioidentical” hormone therapy should not be prescribed routinely when FDA-approved products exist. It notes that many compounding pharmacies use “bioidentical” as a marketing term, and that evidence for claims of extra safety and effectiveness is lacking.2
- The National Academies reviewed the evidence for the FDA and found it insufficient to support the clinical use of compounded bioidentical hormones. They suggested limiting them to people allergic to an ingredient in an approved product, or who need a dosage form approved products don’t offer. They singled out pellets for possible inclusion on the FDA’s Difficult to Compound List, citing the complex delivery and the lack of required bioavailability testing.3
- For testosterone, an international consensus endorsed by the Menopause1 Society and other groups says preparations that produce supraphysiologic, meaning above normal female, testosterone levels, “including pellets and injections,” are not recommended.4
Some clinicians do use estradiol pellets. A 2025 review found they kept estradiol levels steady for four to six months and controlled hot flashes. It linked problems such as bleeding, tachyphylaxis (symptoms returning sooner even with high hormone levels) and very high levels mainly to excessive doses, reinserting too early, or missing uterine protection. The authors called for long-term studies to standardize protocols.5
1. “Is this pellet compounded, or an FDA-approved product?”
Ask for the exact hormone, the dose in milligrams and the pharmacy that makes it. If it is compounded, ask why an FDA-approved patch, gel, spray, ring or pill isn’t suitable for you. The National Academies’ two reasons are an ingredient allergy or a dosage form that isn’t otherwise available.3
Try: “Which approved options did you consider for me, and why do you think a compounded pellet is the better fit?”
2. “What happens if the dose turns out too high?”
A pellet can’t be adjusted the way you can lower a gel dose or take off a patch. Ask what side effects you might notice, what the clinic would do if they happen, and how long the pellet would keep releasing hormone.5
If testosterone is included, ask what blood level the clinic aims for and how that compares with the normal female range, given the consensus warning about supraphysiologic levels.4
3. “How will you protect my uterus?”
If you still have a uterus, estrogen without a progestogen raises the risk of the lining overgrowing. The 2025 pellet review lists missing endometrial protection as a source of safety problems.5 Ask what progestogen you will take, in what form, and what to do about any bleeding.
Try: “If I start spotting or bleeding, who do I call, and how soon do you want to see me?”
4. “How will you decide when I need the next one?”
Ask whether reinsertion is based on your symptoms, a blood test or a fixed calendar, and what levels must fall to before another pellet goes in. The 2025 review linked tachyphylaxis and high levels to reinserting too early.5 If symptoms return quickly, ask about checking your levels before adding another pellet.
5. “What will this cost over a year, and does insurance pay any of it?”
Ask for the price per insertion, how many insertions a year the clinic expects, and the charges for lab work, visits and any progestogen. Check with your insurer whether the pellet, the insertion procedure and the labs are covered. Get the answer in writing before the appointment. Then compare that yearly total with the price of an approved option your plan covers.
Bring a second opinion if you’re unsure
If you’re weighing pellets against other treatments, a gynecologist or a clinician with menopause training can go through your symptoms, history and options. ACOG2 advises clinicians to explain the lack of FDA approval and the risks specific to compounding to anyone who asks for compounded hormones.2 You’re entitled to that explanation before you agree to anything.
My Body Changed. Now What? includes a Visit Brief. Use it to write down your symptoms, the treatment being offered and the five questions above, and to record the answers you get. See the book.
This article is for general educational purposes only and is not medical advice. It isn't a substitute for diagnosis or treatment from a qualified healthcare professional who knows your health history. Please don't ignore professional advice or delay getting care because of something you read here. If you think you may be having a medical emergency, call 911 or your local emergency number right away. This article describes published professional guidance about a category of treatment. It does not describe or evaluate any particular clinic, practitioner, or pharmacy. Girl Playbook does not endorse any specific product, test, or provider.
Girl Playbook sells this book. It provides education and worksheets, not individualized medical care.
Sources
The research behind this article, in the order it’s cited. How we source our articles.
- Menopause (abstract via PubMed), 2022The 2022 hormone therapy position statement of The North American Menopause Society (opens in a new tab)abc
- American College of Obstetricians and Gynecologists (abstract via PubMed), 2023Compounded Bioidentical Menopausal Hormone Therapy: ACOG Clinical Consensus No. 6 (opens in a new tab)abcd
- National Academies of Sciences, Engineering, and Medicine, 2020Prescribers Should Restrict the Use of Non-FDA Approved Compounded Bioidentical Hormones Except for Specific Medical Circumstances (opens in a new tab)ab
- Journal of Clinical Endocrinology & Metabolism, 2019Global Consensus Position Statement on the Use of Testosterone Therapy for Women (opens in a new tab)ab
- Journal of Clinical Medicine (abstract via PubMed), 2025Subcutaneous Estradiol Pellets as Hormone Therapy in Menopause: Clinical Pharmacology, Patient Selection and Safety Considerations (opens in a new tab)abcd
Spotted something out of date? Tell us and we’ll check it.


